| CXSB2101014 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-05-21 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2500008 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2025-01-09 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2300211 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JXSL2101132 | 甘精胰岛素利司那肽注射液2:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-11-17 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd | | | view |
| CYSB2400141 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| JXSL2101131 | 甘精胰岛素利司那肽注射液1:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-11-17 | | Sanofi KK;Sanofi (China) Investment Co Ltd | | | view |
| CXSL2500306 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | New Drug Application | 2025-04-16 | | Yifan Pharmaceutical (Shanghai) Co Ltd | | | view |
| CYSB2101082 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-06-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2400236 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2300082 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.4) | Supplementary Application | 2023-04-13 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| JTS2200006 | OA-Arg-甘精胰岛素 | | Active ingredient | Biological Products | Disposable Import Drug Application | 2022-02-18 | | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2400080 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | Lilly France;Eli Lilly Nederland BV | | | view |
| JYSB2101113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-08-26 | | Sanofi-Aventis Deutschland GmbH | | | view |
| JXSS2101025 | 甘精胰岛素利司那肽注射液2:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-30 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2400174 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYSZ2300013 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2023-02-28 | | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| CYSB2300212 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2200127 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2022-06-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-14 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| CYSB2101251 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-11-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
